Inogen Stock

Inogen EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Inogen (INGN) as of Jul 25, 2026 is -5.55. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -3.95 — a change of 40.75% (lower).

EV/EBIT

-5.55

YoY

40.75%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Inogen is 2026 -5.55 . EV/EBIT (Enterprise Value to EBIT) of Inogen was 2025 -3.95 . It decreases by 40.75% lower compared to the previous year.

The Inogen EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
75.54 base
Jan 1, 2020
-81.90 base
Jan 1, 2021
83.56 base
Jan 1, 2022
-5.30 base
Jan 1, 2023
-1.17 base
Jan 1, 2024
-5.10 base
Jan 1, 2025
-6.05 base
Jan 1, 2026 (e)
-5.81 base
YEARPRICE-TO-EBIT
2026 est -5.81
2025 -6.05
2024 -5.10
2023 -1.17
2022 -5.30
2021 83.56
2020 -81.90
2019 75.54
2018 74.06
2017 95.68
2016 62.76
2015 52.81
2014 60.83
2013 -
2012 -
2011 -
Access this data via the Eulerpool API

Inogen Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Inogen's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Inogen's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Inogen's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Inogen grows earnings faster than its peers.

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

EV/EBIT (Enterprise Value to EBIT) of Inogen is -5.55 in 2026.

Access this data via the Eulerpool API

Valuation — Inogen

All Key Metrics — Inogen